Thursday, October 26, 2006

The role of patentability in FDA approvals

We read that the FDA is changing its rules for the Deciders - removing some of the economic incentive for them to find favorably in matters that benefit them financially.

Need additional step: foster the same degree of testing for natural substances that cannot be patented. Then compare results - the natural, or the lab recreated "identical."

No comments: